Abstract
Aim: To determine the role of HEV in patients with decompensated CLD.
| Original language | English |
|---|---|
| Pages (from-to) | 574-581 |
| Number of pages | 8 |
| Journal | Alimentary Pharmacology and Therapeutics |
| Volume | 42 |
| Issue number | 5 |
| Early online date | 14 Jul 2015 |
| DOIs | |
| Publication status | Published - Sep 2015 |
Fingerprint
Keywords
- liver disease
- hepatitis E
- HEV testing
Cite this
}
Hepatitis E virus in patients with decompensated chronic liver disease: a prospective UK/French study. / Blasco-Perrin, H.; Madden, R.G.; Stanley, A.; Crossan, Claire; Hunter, J.G.; Vine, L.; Lane, K.; Devooght-Johnson, N.; Mclaughlin, C.; Petrik, J.; Stableforth, B.; Hussaini, H.; Phillips, M.; Mansuy, J.M.; Forrest, E.; Izopet, J.; Blatchford, O.; Scobie, Linda; Peron, J.M.; Dalton, H.R.
In: Alimentary Pharmacology and Therapeutics, Vol. 42, No. 5, 09.2015, p. 574-581.Research output: Contribution to journal › Article
TY - JOUR
T1 - Hepatitis E virus in patients with decompensated chronic liver disease: a prospective UK/French study
AU - Blasco-Perrin, H.
AU - Madden, R.G.
AU - Stanley, A.
AU - Crossan, Claire
AU - Hunter, J.G.
AU - Vine, L.
AU - Lane, K.
AU - Devooght-Johnson,, N.
AU - Mclaughlin, C.
AU - Petrik, J.
AU - Stableforth, B.
AU - Hussaini, H.
AU - Phillips, M.
AU - Mansuy, J.M.
AU - Forrest, E.
AU - Izopet, J.
AU - Blatchford, O.
AU - Scobie, Linda
AU - Peron, J.M.
AU - Dalton, H.R.
PY - 2015/9
Y1 - 2015/9
N2 - Background: In developed countries, hepatitis E is a porcine zoonosis caused by hepatitis E virus (HEV) genotype 3. In developing countries, hepatitis E is mainly caused by genotype 1, and causes increased mortality in patients with pre-existing chronic liver disease (CLD).Aim: To determine the role of HEV in patients with decompensated CLD.
AB - Background: In developed countries, hepatitis E is a porcine zoonosis caused by hepatitis E virus (HEV) genotype 3. In developing countries, hepatitis E is mainly caused by genotype 1, and causes increased mortality in patients with pre-existing chronic liver disease (CLD).Aim: To determine the role of HEV in patients with decompensated CLD.
KW - liver disease
KW - hepatitis E
KW - HEV testing
U2 - 10.1111/apt.13309
DO - 10.1111/apt.13309
M3 - Article
VL - 42
SP - 574
EP - 581
JO - Alimentary Pharmacology and Therapeutics
JF - Alimentary Pharmacology and Therapeutics
SN - 0269-2813
IS - 5
ER -